Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab.

ABSTRACT: Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.

SUBMITTER: Hurtado A 

PROVIDER: S-EPMC11646921 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature